Cite
HARVARD Citation
Hannestad, J. et al. (n.d.). P2‐029: RATIONALE AND DESIGN OF A PROSPECTIVE, RANDOMIZED, DOUBLE‐BLIND, DOSE‐COMPARISON SAFETY AND TOLERABILITY STUDY OF GRF6019 IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASE. Alzheimer's & dementia. pp. P677-P678. [Online].